TTRX

Turn Therapeutics Inc.

Healthcare · Biotechnology

$174.44 sample

+0.80 (+0.46%) 1D

Market cap

$310.2B

Price as of

2026-10-04

Latest filing

8-K · 2026-09-24

Alerts

8

Price$174.44 -4.86% 3M daily closessample

185.59170.31

2026-07-072026-07-292026-08-202026-09-102026-10-02

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Sep 24SEC10-Q filed
Sep 15INSInsider sell: General Counsel
Sep 09INSInsider sell: Chief Financial Officer
Aug 31INSInsider buy: General Counsel
Aug 20INSInsider sell: EVP, Operations
Aug 17SEC8-K filed: material event
Aug 07INSInsider sell: General Counsel
Aug 03SEC10-Q filed

Sign up to see the real TTRX record →

Company facts

SEC EDGAR registration

Name: Turn Therapeutics Inc.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: -54sample, -100 to +100
Reporting currency: USD

Who is positioning in TTRX

sample

Insiders: 26 insider transactions over 90 days, net selling, $632.3M
Congress: 2 members traded over 90 days
Institutions · 13F: 6 funds hold $5.9B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$9.2B +9.3% y/y

Q4 2024Q3 2026

Inventory$5.7B +9.7% y/y

Q4 2024Q3 2026

Accounts receivable$4.2B +6.8% y/y

Q4 2024Q3 2026

Total debt$11.7B +22.9% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $106.4B -10.1% 3M
Sample peer B: $190.0B +8.9% 3M
Sample peer C: $54.2B -10.8% 3M
Sample peer D: $144.6B +16.1% 3M
Sample peer E: $258.1B +15.0% 3M